Literature DB >> 10982285

A comparison of inpatient and outpatient ASCT.

N Summers1, U Dawe, D A Stewart.   

Abstract

Outpatient high-dose chemotherapy and autologous stem cell transplantation (ASCT) has been shown to be feasible in terms of physical morbidity and mortality outcomes, but few data exist on the psychosocial impact of delivering such aggressive therapy in this manner. The purpose of this observational study was to compare effects of inpatient (n = 20) and outpatient (n = 21) modes of care on physical status, psychological well-being, quality of life, personal finances and caregiver burden. Most patients were treated according to their preference for inpatient or outpatient care. Those choosing outpatient care were screened for eligibility according to established criteria for ambulatory management. Measures were taken at baseline, then at days 4-6, 12-16 and 30 post ASCT. Results showed that overall, the psychological, physical, social and financial outcomes of the outpatient ASCT group were comparable, to or better than inpatients. Factors that seem to be important for successful outpatient management are previous experience with cancer treatment, a satisfying quality of life, physical well-being, patient's preference for a particular mode of care and physical proximity to the treatment centre. The study results suggest that outpatient ASCT is an efficient, effective and acceptable form of care for motivated patients and caregivers who have the physical and psychological capability and desire to receive cancer treatment in this manner.

Entities:  

Mesh:

Year:  2000        PMID: 10982285     DOI: 10.1038/sj.bmt.1702534

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  8 in total

1.  Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.

Authors:  Jennifer E Vaughn; Megan Othus; Morgan A Powell; Kelda M Gardner; Donelle L Rizzuto; Paul C Hendrie; Pamela S Becker; Paul S Pottinger; Elihu H Estey; Roland B Walter
Journal:  JAMA Oncol       Date:  2015-11       Impact factor: 31.777

Review 2.  Chimeric antigen receptor T-cell therapy: Challenges and framework of outpatient administration.

Authors:  Katie S Gatwood; Bhagirathbhai R Dholaria; Mariana Lucena; Brittney Baer; Bipin N Savani; Olalekan O Oluwole
Journal:  EJHaem       Date:  2021-11-19

3.  Evaluation of a Once-Daily Vancomycin Regimen in an Outpatient Leukemia/Bone Marrow Transplant Clinic (OD-VANCO Study).

Authors:  Cindy Luo; Trana Hussaini; Katie Lacaria; Janice Yeung; Tim T Y Lau; Raewyn C Broady
Journal:  Can J Hosp Pharm       Date:  2014-07

Review 4.  A scoping review of caregiver burden during allogeneic HSCT: lessons learned and future directions.

Authors:  A J Applebaum; M Bevans; T Son; K Evans; M Hernandez; S Giralt; K DuHamel
Journal:  Bone Marrow Transplant       Date:  2016-06-13       Impact factor: 5.483

Review 5.  Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma.

Authors:  M Martino; R M Lemoli; C Girmenia; L Castagna; B Bruno; F Cavallo; M Offidani; I Scortechini; M Montanari; G Milone; L Postacchini; A Olivieri
Journal:  Bone Marrow Transplant       Date:  2016-04-04       Impact factor: 5.483

6.  Economic Evaluation of Chimeric Antigen Receptor T-Cell Therapy by Site of Care Among Patients With Relapsed or Refractory Large B-Cell Lymphoma.

Authors:  Gary H Lyman; Andy Nguyen; Sophie Snyder; Matthew Gitlin; Karen C Chung
Journal:  JAMA Netw Open       Date:  2020-04-01

Review 7.  Multiple Myeloma Outpatient Transplant Program in the Era of Novel Agents: State-of-the-Art.

Authors:  Massimo Martino; Annalisa Paviglianiti; Mara Memoli; Giovanni Martinelli; Claudio Cerchione
Journal:  Front Oncol       Date:  2020-11-11       Impact factor: 6.244

8.  Exploring the caregiver's experience in an innovative homebound hematopoietic stem cell transplantation program.

Authors:  Juliet Jenkelowitz; Margaux Genoff Garzon; Kathleen Lynch; Elyse Shuk; Eva Feindler; Heather Landau; Allison Applebaum
Journal:  Palliat Support Care       Date:  2021-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.